Caxton Associates (UK)’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.46M Sell
316,136
-302,172
-49% -$1.58M 0.03% 288
2025
Q4
$3.09M Sell
618,308
-124,418
-17% -$648K 0.06% 117
2025
Q3
$3.77M Buy
742,726
+124,900
+20% +$550K 0.09% 96
2025
Q2
$2.66M Buy
617,826
+330,946
+115% +$1.64M 0.07% 142
2025
Q1
$1.73M Buy
+286,880
New +$1.45M 0.06% 188

Other funds holding MPT

Caxton Associates (UK)'s MPT Position: Q1 2026 in Review

Caxton Associates (UK) reduced its Medical Properties Trust (MPT) stake by 49% in Q1 2026, selling an estimated $1.58M and leaving 316,136 shares worth $1.46M. The position accounts for 0.03% of the portfolio, ranked #288.

Caxton Associates (UK) first reported a position in MPT in Q1 2025 and has held it in 5 quarters since. The position peaked at $3.77M in Q3 2025. 491 funds tracked by Wall St. Rank hold MPT as of Q1 2026.

  • Caxton Associates (UK) held 316,136 shares of Medical Properties Trust worth $1.46M as of Q1 2026.
  • Caxton Associates (UK) sold 302,172 Medical Properties Trust shares in Q1 2026, an estimated $1.58M.
  • Medical Properties Trust made up 0.03% of Caxton Associates (UK)'s portfolio in Q1 2026, its #288 holding.
  • Caxton Associates (UK) first reported a position in Medical Properties Trust in Q1 2025 and has held it in 5 quarters since.
  • Caxton Associates (UK)'s Medical Properties Trust position peaked at $3.77M in Q3 2025.
  • 491 funds tracked by Wall St. Rank held Medical Properties Trust as of Q1 2026.

Based on Caxton Associates (UK)'s 13F filing for Q1 2026, filed 14 May 2026.